Timber Pharmaceuticals, Inc.
Timber Pharmaceuticals, Inc. (TMBR) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · TMBR · as of Jun 9, 2026
Key Statistics
Explore Timber Pharmaceuticals, Inc. Data
tmbr stock data · financialsAnalyst Ratings & Price Target
Full ForecastTotal: 1 · Buy rate: 0.0%
Competitors & Peers
tmbr competitorsTMBR
BLCM
CWBR
CYTO
HTGMQ
IMPLAbout Timber Pharmaceuticals, Inc.
Timber Pharmaceuticals, Inc. operates as a clinical-stage biopharmaceutical company, specializing in the research, development, and market introduction of treatments for rare dermatological conditions…
what is timber pharmaceuticals, inc. · tmbr stock overview · timber pharmaceuticals, inc. company profile · who is timber pharmaceuticals, inc. ceo · tmbr AMEX · timber pharmaceuticals, inc. headquarters · timber pharmaceuticals, inc. business segments
About Stock Overview & Key Data
Timber Pharmaceuticals, Inc. (TMBR) is a Healthcare company in the Biotechnology industry, listed on AMEX since Sep 8, 2014. As of the latest trading session, TMBR stock price is $0.34, with a market capitalization of $1.2M. The stock has returned — over the past 12 months and — year-to-date.
Frequently Asked Questions
As of the latest trading session, Timber Pharmaceuticals, Inc. (TMBR) stock price is $0.34. The stock is traded on AMEX under the ticker symbol TMBR. The 52-week range is $0.32 – $3.39.